Loading...
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer
Multidrug resistance (MDR) is considered as a primary hindrance for paclitaxel failure in non-small cell lung cancer (NSCLC) patients, in which P-glycoprotein (P-gp) is overexpressed and the PI3K/Akt signaling pathway is dysregulated. Previously, we designed and synthesized DHW-221, a dual PI3K/mTOR...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Frontiers Media S.A.
2022-05-01
|
Serier: | Frontiers in Oncology |
Fag: | |
Online adgang: | https://www.frontiersin.org/articles/10.3389/fonc.2022.873649/full |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|